undamentalytics Newsletter
Sign in

Invo Fertility, Inc. income statement

In fiscal 2025, Invo Fertility, Inc. reported revenue of $6.8m, up 4.7% on the year before, operating income of −$7.2m (a -105.8% margin) and net income of −$23.3m, or −$8585.51 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0000000011413778
Cost of revenue——————000000240—
Gross profit000000001140137—
Research and development————————000100——
Selling, general and administrative11121213369107888
Operating income−1−1−1−2−1−2−1−3−2−6−5−11−7−7−7−6
Interest expense0000000003101111
Income before tax−1−1−1−2−5−2−1−3−2−8−7−11−8−8−5—
Income tax00000000000000−0—
Net income−1−1−1−2−5−2−1−3−2−8−7−11−8−9−23−7
Diluted EPS−$1727.93−$7.20−$7.20−$14.40−$6911.72−$14.40$0.00−$14.40−$77756.83−$1094.36−$907.16−$310508.96−$97008.85−$151304.48−$8585.51—
Diluted shares (average)————————————————
EBITDA−1−1−1−2−1−2−1−3−2−6−5−11−7−6−7−5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: IVF vs XAIRIVF vs NNNNIVF vs NUWE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Invo Fertility, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Invo Fertility, Inc.